BIOTECH AUSTRIA, the first branch association specifically for the biotechnology industry in Austria was founded on December 10, 2020. LISAvienna appreciates this initiative and became a member.

The aim of BIOTECH AUSTRIA is to establish an independent, self-contained interest group for Austrian biotechnology, to promote an innovative and financially strong branch of industry within the Austrian economy and to represent Austrian biotechnology at home and abroad. In order to make better use of synergy effects and to be able to speak with one voice in politics and society, BIOTECH AUSTRIA also intends to cooperate closely with other associations and clusters in Austria as well as with biotech organizations in Europe and the USA.

Information on the new association and its members is available here:

Are you interested in joining in? Contact BIOTECH AUSTRIA at .

We thank the founding members for their commitment:

  • Peter Llewellyn-Davies, CEO APEIRON Biologics AG
  • Georg Casari, CEO Haplogen GmbH
  • Reinhard Kandera, CFO HOOKIPA Pharma Inc.
  • Alexander Seitz, CINO Lexogen GmbH

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)